Informations générales (source: ClinicalTrials.gov)

NCT06490757 Recrutement non commencé
A Phase 2 Open-label Single-arm Trial of JAK1 Inhibitor for the Treatment of Large Inflammatory Hepatocellular Adenomas
18 septembre 2025

Critères